Showing results (491-500 of 689) with videos related to

Sort By:
Pageof 69
Circulation|April 17, 2002
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptideMarc S Sabatine, David A Morrow, James A de Lemos, et al.
Archivos Argentinos De Pediatria|September 6, 2014
Epidemiological situation of pertussis and strategies to control it: Argentina, 2002-2011Viviana Romanin, Vanina Agustinho, Gloria Califano, et al.
American Heart Journal|May 17, 2005
Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trialJessica L Mega, David A Morrow, Marc S Sabatine, et al.
European Heart Journal|June 15, 2007
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysisRoberto R Giraldez, José Carlos Nicolau, Ramon Corbalan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatinL J Ayash, A Elias, G Schwartz, et al.
European Journal of Heart Failure|June 29, 2016
Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48Giulia Magnani, Robert P Giugliano, Christian T Ruff, et al.
The New England Journal of Medicine|October 31, 1996
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromesE M Antman, M J Tanasijevic, B Thompson, et al.
Plos One|September 19, 2019
Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trialRaymond Y Kwong, Bobak Heydari, Yin Ge, et al.
The American Journal of Medicine|March 21, 2016
Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 TrialRobert P Giugliano, Christian T Ruff, Stephen D Wiviott, et al.
Circulation|March 30, 2006
Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary interventionAlice K Jacobs, Elliott M Antman, Gray Ellrodt, et al.
Pageof 69